-
-
-
-
-
-
-
Form 3 Big Cypress Acquisition For: Oct 22 Filed by: Randall Charles Hiram
-
-
-
-
-
-
-
Form 3 Big Cypress Acquisition For: Oct 22 Filed by: Beyer Russell P
-
-
-
-
-
-
-
Form 4 Big Cypress Acquisition For: Oct 14 Filed by: Reich Samuel J
-
-
-
-
-
-
-
SAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19 (BCYP)
-
-
-
-
-
-
-
SAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 Variants (BCYP)
-
-
-
-
-
-
-
Big Cypress Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination with SAB Biotherapeutics
-
-
-
-
-
-
-
Big Cypress Acquisition Corp. Announces Closing of $115 Million Initial Public Offering, which Includes Full Exercise of the Underwriters' Over-Allotment Option
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

